Group Medicare Advantage
Search documents
Humana (HUM) Reports Q3 Earnings: What Key Metrics Have to Say
ZACKS· 2025-11-05 15:36
Humana (HUM) reported $32.65 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 11.4%. EPS of $3.24 for the same period compares to $4.16 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $31.98 billion, representing a surprise of +2.09%. The company delivered an EPS surprise of +11.34%, with the consensus EPS estimate being $2.91.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Str ...
CVS Health Sees Momentum in HCB Segment Amid Utilization Pressure
ZACKS· 2025-09-02 13:41
Core Insights - CVS Health's Health Care Benefits segment reported strong performance in Q2 2025, with revenues exceeding $36 billion, reflecting an over 11% increase year-over-year, primarily driven by government business growth influenced by the 2022 Inflation Reduction Act [1][8] - The company plans to exit the individual exchange business in 2026, anticipating variable losses between $350 million and $400 million for 2025 due to ongoing performance challenges [2][8] - CVS recorded a $471 million premium deficiency reserve related to its Group Medicare Advantage product line, raising the medical benefit ratio to 89.9%, a 30-basis-point increase from the previous year [3][4] Financial Performance - The adjusted operating income for CVS Health surged nearly 40%, benefiting from favorable changes in individual exchange risk adjustment estimates and stronger government business performance [1][8] - Medical membership as of June 30 decreased to 26.7 million, attributed to expected declines following the expiration of a premium grace period [2] - Days' claims payable improved to 40.9 days, a reduction of approximately 2 days sequentially, driven by a higher mix of pharmacy costs [4] Competitive Landscape - Elevance Health reported Q2 2025 operating revenues of $41.6 billion, a 12% year-over-year increase, mainly due to higher premium yields and growth in Medicare Advantage membership [5] - Humana's performance was bolstered by its CenterWell pharmacy and improved individual Medicare Advantage membership, alongside strategic Medicaid expansion efforts [6] Stock Performance and Valuation - CVS Health shares have appreciated by 27.5% over the past year, contrasting with a 16.7% decline in the industry [7] - The company is currently trading at a forward five-year earnings multiple of 10.65, below the industry average of 15.33, and holds a Value Score of A [9] - Consensus estimates for CVS's earnings in 2025 and 2026 show a bullish trend, with current estimates at 6.32 for 2025 and 7.14 for 2026 [10][11]
Curious about Humana (HUM) Q2 Performance? Explore Wall Street Estimates for Key Metrics
ZACKS· 2025-07-29 05:06
Core Insights - Humana (HUM) is expected to report quarterly earnings of $6.32 per share, reflecting a decline of 9.2% year over year, while revenues are forecasted to reach $31.78 billion, an increase of 8.2% year over year [1] Earnings Estimates - Analysts have revised the consensus EPS estimate down by 0.1% over the past 30 days, indicating a collective reassessment of projections [1][2] Revenue Breakdown - 'Revenues- Premiums' are projected to be $30.23 billion, showing a year-over-year increase of 7.4% [4] - 'Revenues- Services' are estimated at $1.31 billion, indicating a significant year-over-year growth of 19% [4] - 'Revenues- Investment income (loss)' is expected to be $270.96 million, reflecting a decline of 9.1% from the previous year [4] - 'Revenue- Insurance' is anticipated to reach $30.71 billion, marking a 7.7% increase from the prior year [5] Membership Metrics - 'Medical Membership - Medicare stand-alone PDP' is projected to reach 2.45 million, up from 2.34 million in the same quarter last year [6] - 'Medical Membership - State-based contracts and other' is expected to be 1.62 million, compared to 1.39 million a year ago [6] - 'Medical Membership - Group Medicare Advantage' is estimated at 562.63 thousand, an increase from 544.90 thousand year-over-year [7] - 'Medical Membership - Medicare Supplement' is forecasted to reach 419.63 thousand, up from 339.20 thousand in the same quarter last year [7] - 'Medical Membership - Individual Medicare Advantage' is expected to decline to 5.18 million from 5.62 million year-over-year [8] - Total 'Medical Membership - Total Medicare' is projected at 8.19 million, down from 8.50 million a year ago [8] - 'Medical Membership - Military services' is estimated to be 4.94 million, compared to 5.96 million in the previous year [9] Stock Performance - Humana shares have decreased by 1.6% over the past month, contrasting with a 4.9% increase in the Zacks S&P 500 composite [9]